AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34347136 — intervention group
Group type: EXPERIMENTAL
Intervention: PIDENT scoring model for predicting non-diagnostic evaluation of DES-ISR
Number of subjects: 757
Study 34347136 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline characteristics including implanted stent diameter, severe calcification, stent-in-stent lesion, and type of DES
Number of subjects: 757
Study 34347136 — intervention group
Group type: COMPARATOR
Intervention: Non-diagnostic evaluation of DES
Number of subjects: 757
Study 32628547 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine Treatment with Metoclopramide Coadministration
Number of subjects: 0
Study 32628547 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine Treatment without Metoclopramide Coadministration
Number of subjects: 0
Study 32628547 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35590182 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol responsibility messages with modified content (direct language and consequence)
Number of subjects: 121
Study 35590182 — intervention group
Group type: COMPARATOR
Intervention: Alcohol responsibility messages with variances in type size or type contrast
Number of subjects: 121
Study 32444343 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIE (High-Intensity Interval Exercise): cycling for 4×4 min at 85%-95% of heart rate peak (HRpeak), interspersed with 3 min of active recovery at 60%-70% HRpeak
Number of subjects: 24
Study 32444343 — intervention group
Group type: EXPERIMENTAL
Intervention: MICE (Moderate-Intensity Continuous Exercise): 33 min of continuous cycling at 60%-70% HRpeak
Number of subjects: 24
Study 32444343 — intervention group
Group type: COMPARATOR
Intervention: CON (Control): lying quietly in a supine position for 30 min
Number of subjects: 24
Study 36370162 — intervention group
Group type: EXPERIMENTAL
Intervention: Decon group (step-wise teaching with educational videos)
Number of subjects: 64
Study 36370162 — intervention group
Group type: COMPARATOR
Intervention: Trad group (traditional method with continuous demonstration)
Number of subjects: 64
Study 33804824 — intervention group
Group type: EXPERIMENTAL
Intervention: Field IBV strains
Number of subjects: 69
Study 33804824 — intervention group
Group type: COMPARATOR
Intervention: Vaccine IBV strains
Number of subjects: 69
Study 33804824 — intervention group
Group type: EXPERIMENTAL
Intervention: IBV genome sequences
Number of subjects: 69
Study 33804824 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombination hot spots
Number of subjects: 69
Study 32865229 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher emotion knowledge (EK) at the end of pre-K
Number of subjects: 1050
Study 32865229 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion knowledge (EK) interventions and strategies in pre-K programs
Number of subjects: 1050
Study 34463630 — intervention group
Group type: EXPERIMENTAL
Intervention: Noom app user group (n=20)
Number of subjects: 40
Study 34463630 — intervention group
Group type: COMPARATOR
Intervention: Non-Noom user group (n=20)
Number of subjects: 40
Study 32507432 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniofacial massage (n = 25)
Number of subjects: 50
Study 32507432 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 25)
Number of subjects: 50
Study 35212802 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioresorbable-polymer sirolimus-eluting stent (BP-SES)
Number of subjects: 2350
Study 35212802 — intervention group
Group type: EXPERIMENTAL
Intervention: Durable-polymer everolimus-eluting stent (DP-EES)
Number of subjects: 2350
Study 35212802 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex PCI
Number of subjects: 2350
Study 35212802 — intervention group
Group type: COMPARATOR
Intervention: Non-complex PCI
Number of subjects: 2350
Study 36455453 — intervention group
Group type: EXPERIMENTAL
Intervention: PEA‐LUT 700 mg + 70 mg
Number of subjects: 39
Study 36455453 — intervention group
Group type: COMPARATOR
Intervention: PLACEBO
Number of subjects: 39
Study 33994141 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency feeding services during the COVID-19 pandemic
Number of subjects: 34
Study 32938462 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based health insurance (CBHI) uptake
Number of subjects: 845
Study 32938462 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to pay for CBHI
Number of subjects: 845
Study 35488222 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise programme (3 sessions per week of moderate-intensity aerobic exercise using a cycle ergometer)
Number of subjects: 73
Study 35488222 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise programme
Number of subjects: 73
Study 35488222 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 73
Study 34183431 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4304
Study 36259143 — intervention group
Group type: EXPERIMENTAL
Intervention: eTansiyon smartphone application
Number of subjects: 185
Study 33994233 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonintubated thoracoscopic lobectomy
Number of subjects: 252
Study 33994233 — intervention group
Group type: COMPARATOR
Intervention: Intubated thoracoscopic lobectomy
Number of subjects: 252
Study 32210289 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automated detection algorithm for CIED infections
Number of subjects: 5703
Study 32210289 — intervention group
Group type: COMPARATOR
Intervention: Manual review of CIED procedures
Number of subjects: 5703
Study 35345936 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week education program consisting of 6 sessions
Number of subjects: 138
Study 35345936 — intervention group
Group type: COMPARATOR
Intervention: No educational intervention (Control)
Number of subjects: 138
Study 33570158 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) program, 5 days a week, once a day, for 8 weeks, with progressive intensity from 15% to 60% of PImax.
Number of subjects: 16
Study 33570158 — intervention group
Group type: COMPARATOR
Intervention: Placebo group performing the same program with a fixed load of 7cmH20.
Number of subjects: 16
Study 33570158 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (IMT)
Number of subjects: 16
Study 33570158 — intervention group
Group type: COMPARATOR
Intervention: Both groups (IMT and placebo)
Number of subjects: 16
Study 34992123 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment of venous leg ulcers with community staff involvement
Number of subjects: 9
Study 34992123 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of antimicrobial dressings
Number of subjects: 9
Study 34992123 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound care delivered in the home
Number of subjects: 9
Study 34992123 — intervention group
Group type: EXPERIMENTAL
Intervention: National cost of treating venous leg ulcers
Number of subjects: 9
Study 34399166 — intervention group
Group type: EXPERIMENTAL
Intervention: eNose analysis for early monitoring during anti-PD-1 therapy
Number of subjects: 94
Study 36114831 — intervention group
Group type: EXPERIMENTAL
Intervention: RAM cannula
Number of subjects: 254
Study 36114831 — intervention group
Group type: COMPARATOR
Intervention: Short binasal prongs (SBP)
Number of subjects: 254
Study 33750646 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN-812 200 mg
Number of subjects: 313
Study 33750646 — intervention group
Group type: EXPERIMENTAL
Intervention: SPN-812 400 mg
Number of subjects: 313
Study 33750646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study 36395192 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 minutes of balance training followed by 1 hour and 30 minutes of ordinary badminton training, 2 days per week for 8 weeks
Number of subjects: 20
Study 36395192 — intervention group
Group type: COMPARATOR
Intervention: 2 hours of ordinary badminton training
Number of subjects: 20
Study 33846037 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity follow-up (examinations at 6, 12, 18, 24, and 36 months)
Number of subjects: 2509
Study 33846037 — intervention group
Group type: COMPARATOR
Intervention: Low-intensity follow-up (examinations at 12 and 36 months)
Number of subjects: 2509
Study 33846037 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated CEA levels before treatment
Number of subjects: 2509
Study 33846037 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated CEA levels after surgery
Number of subjects: 2509
Study 34183458 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention
Number of subjects: 89
Study 34183458 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 89
Study 34183458 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention in polypharmacy patients
Number of subjects: 89
Study 34183458 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention in patients aged >60 years
Number of subjects: 89
Study 34183458 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led educational intervention in patients with high education level
Number of subjects: 89
Study 32692247 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT) alone 300 cGy/fraction ×10 fractions, total dose 3,000 cGy
Number of subjects: 80
Study 32692247 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT) alone 180 cGy/fraction ×22 fractions, total dose 3,960 cGy
Number of subjects: 80
Study 32692247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracranial metastases radiotherapy alone 250 cGy/fraction ×22 fractions, total dose 5,500 cGy
Number of subjects: 80
Study 32692247 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain + intracranial metastases group (SIB) whole brain 180 cGy/fraction ×22 fractions, intracranial metastases 250 cGy/fraction ×22 fractions, total doses 3,960 cGy and 5,500 cGy respectively
Number of subjects: 80
Study 32692247 — intervention group
Group type: COMPARATOR
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 80
Study 32692247 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain + intracranial metastases group (SIB)
Number of subjects: 80
Study 36386372 — intervention group
Group type: EXPERIMENTAL
Intervention: MUSKARDIA
Number of subjects: 776
Study 36386372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 776
Study 32233902 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (atDCS)
Number of subjects: 30
Study 32233902 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study 35411785 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy
Number of subjects: 3699
Study 35411785 — intervention group
Group type: COMPARATOR
Intervention: Control (non-invasive strategy)
Number of subjects: 3699
Study 34052007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (0.2 mg/kg single dose)
Number of subjects: 69
Study 34052007 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 69
Study 32579810 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 530
Study 32579810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study 35621233 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-Day Discharge (SDD) after TAVI
Number of subjects: 158591
Study 35621233 — intervention group
Group type: COMPARATOR
Intervention: Next-Day Discharge after TAVI
Number of subjects: 158591
Study 35621233 — intervention group
Group type: COMPARATOR
Intervention: Second or Third Day Discharge after TAVI
Number of subjects: 158591
Study 35621233 — intervention group
Group type: COMPARATOR
Intervention: Non-Same-Day Discharge (Non-SDD) after TAVI
Number of subjects: 158591
Study 34912021 — intervention group
Group type: EXPERIMENTAL
Intervention: Split tablet regimen (group S)
Number of subjects: 66
Study 34912021 — intervention group
Group type: COMPARATOR
Intervention: Alternate-day regimen (group A)
Number of subjects: 66
Study 34912021 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (S and A)
Number of subjects: 66
Study 34262120 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular exercise (VE) for 20 min using a virtual reality system once a week for 4 weeks
Number of subjects: 28
Study 34262120 — intervention group
Group type: EXPERIMENTAL
Intervention: Vestibular exercise (VE) for 20 min using a virtual reality system once a week for 4 weeks + optokinetic stimulation (OS) for 9 min
Number of subjects: 28
Study 34544754 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of erector spinae block and retrolaminar block (10 mL each)
Number of subjects: 8
Study 34544754 — intervention group
Group type: COMPARATOR
Intervention: Erector spinae block (20 mL)
Number of subjects: 8
Study 36243227 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct consultations with medical physicists during treatment simulation and before the first treatment.
Number of subjects: 0
Study 36243227 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group).
Number of subjects: 0
Study 36243227 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct consultations with medical physicists.
Number of subjects: 0
Study 33726983 — intervention group
Group type: EXPERIMENTAL
Intervention: 12th grade letter
Number of subjects: 909
Study 33726983 — intervention group
Group type: EXPERIMENTAL
Intervention: 12th grade infographic
Number of subjects: 909
Study 33726983 — intervention group
Group type: EXPERIMENTAL
Intervention: 6th grade infographic
Number of subjects: 909
Study 33726983 — intervention group
Group type: EXPERIMENTAL
Intervention: 6th grade letter
Number of subjects: 909
Study 33726983 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirect understanding of abnormal test results
Number of subjects: 909
Study 33726983 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 909
Study 35990583 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice daily by mouth in 21-day cycles)
Number of subjects: 70
Study 35990583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35990583 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib
Number of subjects: 70
Study 34983471 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscosupplementation (single-dose intraarticular hyaluronic acid injection)
Number of subjects: 47
Study 34983471 — intervention group
Group type: COMPARATOR
Intervention: Control (no viscosupplementation)
Number of subjects: 47
Study 34983471 — intervention group
Group type: EXPERIMENTAL
Intervention: Viscosupplementation
Number of subjects: 47
Study 34983471 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 47
Study 34480134 — intervention group
Group type: EXPERIMENTAL
Intervention: Polygenic risk score (PGGRS) calculated using 13 SNPs
Number of subjects: 4592
Study 34480134 — intervention group
Group type: COMPARATOR
Intervention: Models without PGGRS (Cox, ANN, RF, GBM)
Number of subjects: 4592
Study 34480134 — intervention group
Group type: EXPERIMENTAL
Intervention: Models with PGGRS (Cox, ANN, RF, GBM)
Number of subjects: 4592
Study 35395598 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise program (n=8)
Number of subjects: 14
Study 35395598 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise program (n=6)
Number of subjects: 14
Study 32069192 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgender heterosexual female defendants
Number of subjects: 300
Study 32069192 — intervention group
Group type: COMPARATOR
Intervention: Cisgender gay male defendants
Number of subjects: 300
Study 32069192 — intervention group
Group type: EXPERIMENTAL
Intervention: All defendants
Number of subjects: 300
Study 32069192 — intervention group
Group type: EXPERIMENTAL
Intervention: Transgender defendants
Number of subjects: 300
Study 33316455 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP therapy with lifestyle counseling
Number of subjects: 0
Study 33316455 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle counseling alone
Number of subjects: 0
Study 36480147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lysine acetylsalicylate (LA) 450 mg plus oral ticagrelor 180 mg
Number of subjects: 32
Study 36480147 — intervention group
Group type: COMPARATOR
Intervention: Oral aspirin 300 mg plus ticagrelor 180 mg
Number of subjects: 32
Study 36480147 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous lysine acetylsalicylate (LA)
Number of subjects: 32
Study 36480147 — intervention group
Group type: COMPARATOR
Intervention: Oral aspirin
Number of subjects: 32
Study 34453015 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid program based on virtual and real games
Number of subjects: 24
Study 34453015 — intervention group
Group type: COMPARATOR
Intervention: Conventional program based on adapted sports
Number of subjects: 24
Study 32571870 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab 150 or 300 mg, every 4 or 8 weeks during a 72-week period
Number of subjects: 61
Study 34508154 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescribed pace
Number of subjects: 0
Study 34508154 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill
Number of subjects: 0
Study 34508154 — intervention group
Group type: COMPARATOR
Intervention: Overweight individuals
Number of subjects: 0
Study 34535961 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 219
Study 34535961 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased physical activity
Number of subjects: 219
Study 36382458 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic identification model based on knee MRI radiomics
Number of subjects: 228
Study 32961834 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic activity monitor
Number of subjects: 40
Study 32961834 — intervention group
Group type: COMPARATOR
Intervention: Pedometer
Number of subjects: 40
Study 35658959 — intervention group
Group type: EXPERIMENTAL
Intervention: IF2-P
Number of subjects: 20
Study 35658959 — intervention group
Group type: COMPARATOR
Intervention: IF1-P
Number of subjects: 20
Study 32238534 — intervention group
Group type: EXPERIMENTAL
Intervention: P‐ESDM plus MBSR
Number of subjects: 61
Study 32238534 — intervention group
Group type: COMPARATOR
Intervention: P‐ESDM only
Number of subjects: 61
Study 32238534 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 34000940 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized-Targeted Cognitive Training
Number of subjects: 109
Study 34000940 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group (no training)
Number of subjects: 109
Study 34406839 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful awareness practices (MAPs)
Number of subjects: 247
Study 34406839 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship education (SE)
Number of subjects: 247
Study 34406839 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC)
Number of subjects: 247
Study 32492682 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS-Strain Elastography (SE) with mean strain <115
Number of subjects: 327
Study 32492682 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of EBUS-SE (<115) with size (<8 mm) and FDG-PET information
Number of subjects: 327
Study 32492682 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of size and SE
Number of subjects: 327
Study 32492682 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG-PET available subset analysis
Number of subjects: 327
Study 32245307 — intervention group
Group type: EXPERIMENTAL
Intervention: Guluronic acid (G2013) administered orally at a dose of 500 mg twice daily for 12 weeks
Number of subjects: 12
Study 35027330 — intervention group
Group type: EXPERIMENTAL
Intervention: Suburethral adjustment-controlled tape (SACT)
Number of subjects: 125
Study 35027330 — intervention group
Group type: COMPARATOR
Intervention: Transobturator tape (TOT) midurethral sling (MUS)
Number of subjects: 125
Study 34101934 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA plus single-dose DEX (12 mg on day 1) with no further DEX (DEX1)
Number of subjects: 228
Study 34101934 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPA plus single-dose DEX (12 mg on day 1) with oral DEX (4 mg daily) on days 2-3 (DEX3)
Number of subjects: 228
Study 34101934 — intervention group
Group type: COMPARATOR
Intervention: DEX (4 mg twice daily) on days 2-4 (DEX4)
Number of subjects: 228
Study 34101934 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (DEX1, DEX3, DEX4)
Number of subjects: 228
Study 33048789 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 65
Study 34990999 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS intervention (20 daily sessions, 900 pulses per day for 4 weeks)
Number of subjects: 40
Study 34990999 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 40
Study 34091568 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led cognitive behavioral therapy intervention
Number of subjects: 94
Study 32429867 — intervention group
Group type: EXPERIMENTAL
Intervention: The Guide Cymru (mental health literacy programme)
Number of subjects: 30000
Study 32429867 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (no intervention initially)
Number of subjects: 30000
Study 32429867 — intervention group
Group type: EXPERIMENTAL
Intervention: The Guide Cymru (after 12 weeks for control group)
Number of subjects: 30000
Study 32429867 — intervention group
Group type: EXPERIMENTAL
Intervention: The Guide Cymru
Number of subjects: 30000
Study 33605168 — intervention group
Group type: EXPERIMENTAL
Intervention: Play it Safe! program (intervention group)
Number of subjects: 539
Study 33605168 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 539
Study 33287581 — intervention group
Group type: EXPERIMENTAL
Intervention: Early pulmonary rehabilitation (DHPR)
Number of subjects: 53
Study 33287581 — intervention group
Group type: COMPARATOR
Intervention: Delayed pulmonary rehabilitation (PHPR)
Number of subjects: 53
Study 33287581 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events in DHPR
Number of subjects: 53
Study 35533665 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary educational program (9-week duration)
Number of subjects: 64
Study 35533665 — intervention group
Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 64